Apply For a Grant

METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.

2021 Grant Cycle 

 

METAvivor Research Award: Up to 2 years, $250,000 award for established investigators.

Application Portal Opens: January 25, 2021
Required LOI Deadline: March 26, 2021
Invitations to Submit Full Application: on or by May 19, 2021
Invited Applications Deadline: by 11:59 PM ET on August 25, 2021
Announcement of Awardees: on or by December 17, 2021​​​​​​​

METAvivor Early Career Investigator Award: Up to 2 years, $100,000 award available to early career applicants (investigators within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started).

Application Portal Opens: January 25, 2021
Required LOI Deadline: March 24, 2021
Invitations to Submit Full Application: on or by May 17, 2021
Invited Applications Deadline: by 11:59 PM ET on August 23, 2021
Announcement of Awardees: on or by December 17, 2021​​​​​​​

METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.

Thank you for your interest and participation.